To this aim, we tested the presence of proliferating cell nuclear antigen (PCNA), a cell marker used in MM patients to evaluate the proliferation of clonal plasma cells, and a parameter which also parallels the tumor histological grade [38]. The gene discussed is PCNA; the disease is Miyoshi myopathy.